hematoporphyrin has been researched along with piroxicam in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Itoi, E; Miyakoshi, N; Nakajima, M; Nishida, J; Okada, K; Suzuki, T | 1 |
Bunker, A; Cramariuc, O; Kepczynski, M; Li, YC; Mirza, S; Rissanen, S; Róg, T; Stepniewski, M; Wytrwal, M; Xhaard, H | 1 |
3 other study(ies) available for hematoporphyrin and piroxicam
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Enhanced antitumor effect of ultrasound in the presence of piroxicam in a mouse air pouch model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Hematoporphyrins; Histidine; Male; Mice; Mice, Inbred ICR; Piroxicam; Reactive Oxygen Species; Sarcoma 180; Survival Rate; Ultrasonic Therapy | 2002 |
Study of interaction between PEG carrier and three relevant drug molecules: piroxicam, paclitaxel, and hematoporphyrin.
Topics: Drug Carriers; Hematoporphyrins; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Paclitaxel; Piroxicam; Polyethylene Glycols | 2012 |